BioCardia (BCDA) Amortizatization of Intangibles (2021 - 2026)
BioCardia's (BCDA) quarterly Amortizatization of Intangibles came in at $121000.0 in Q2 2026, up 2.54% year-over-year from $118000.0 in Q2 2025, and little changed quarter-over-quarter from $121000.0 in Q1 2026.
Powered by 
Analysis
BioCardia (BCDA) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends
BioCardia (BCDA) has reported Amortizatization of Intangibles for 6 consecutive years, with $121000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Amortizatization of Intangibles rose 2.54% year-over-year to $121000.0 in Q2 2026; TTM through Jun 2026 was $484000.0, a 11.19% decrease from a year earlier, with the FY2025 full-year figure at $481000.0, changed 0.21% from the prior year.
- Amortizatization of Intangibles was $121000.0 for Q2 2026 at BioCardia, roughly flat from $121000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $214000.0 in Q4 2024 and troughed at $60000.0 in Q3 2025.
- A 5-year average of $101500.0 and a median of $86000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles plunged 53.09% in 2022 and surged 151.76% in 2024, its largest moves.
- Over 5 years, Amortizatization of Intangibles stood at $76000.0 in 2022, then increased by 11.84% to $85000.0 in 2023, then surged by 151.76% to $214000.0 in 2024, then declined by 14.95% to $182000.0 in 2025, then slumped by 33.52% to $121000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $121000.0 (Q2 2026), $121000.0 (Q1 2026), and $182000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn | 210,000.00 |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn | 902,000.00 |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn | 7.70 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn | -3.57 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - | 64,000.00 |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn | 208,000.00 |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn | -905,000.00 |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn | 1.40 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - | 121,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 121,000.00 |
| Mar 31, 2026 | 121,000.00 |
| Dec 31, 2025 | 182,000.00 |
| Sep 30, 2025 | 60,000.00 |
| Jun 30, 2025 | 118,000.00 |
| Mar 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Sep 30, 2024 | 92,000.00 |
| Jun 30, 2024 | 89,000.00 |
| Mar 31, 2024 | 87,000.00 |
| Dec 31, 2023 | 85,000.00 |
| Sep 30, 2023 | 83,000.00 |
| Jun 30, 2023 | 80,000.00 |
| Mar 31, 2023 | 79,000.00 |
| Dec 31, 2022 | 76,000.00 |
| Sep 30, 2022 | 75,000.00 |
| Jun 30, 2022 | 73,000.00 |
| Mar 31, 2022 | 71,000.00 |
| Dec 31, 2021 | 162,000.00 |
| Sep 30, 2021 | 144,000.00 |